ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Graiteshares Bloomberg Comm Broad Strategy No K 1 ETF

Graiteshares Bloomberg Comm Broad Strategy No K 1 ETF (COMB)

19.90
-0.19
(-0.95%)
Closed January 05 4:00PM
19.89
-0.01
(-0.05%)
After Hours: 7:59PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
19.90
Bid
-
Ask
-
Volume
81,898
19.88 Day's Range 20.0104
18.90 52 Week Range 21.59
Previous Close
20.09
Open
20.00
Last Trade
203
@
19.9
Last Trade Time
Average Volume (3m)
21,755
Financial Volume
$ 1,630,838
VWAP
19.913

COMB Latest News

GraniteShares’ COMB Commodity ETF Tops $100 Million in Assets

Threshold crossed as commodities stage a comeback fueled by global economic recovery NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) -- The GraniteShares Bloomberg Commodity Broad Strategy No K-1 ETF...

Cie du Bois Sauvage : Augmentation du capital par l'exercice de droits de souscription

Communiqué en vertu des dispositions de la loi du 2 mai 2007Information réglementée Augmentation du capital par l'exercice de droits de souscription Suite aux décisions prises par...

Cie du Bois Sauvage: Capital increase through the exercise of subscription rights

Press release in accordance with the provisions of the Law of May 2, 2007Regulated Information Capital increase through the exercise of subscription rights Following the decisions taken by the...

Tous les points à l'ordre du jour de l'Assemblée Générale Ordinaire du 25 avril 2018 ont été approuvés, y compris le p...

COMMUNIQUE DE PRESSE Information réglementée        Compagnie du Bois Sauvage a tenu ce 25 avril 2018 son Assemblée Générale Ordinaire à son siège social. Les actionnaires ont approuvé tous les...

All agenda items were approved at the Ordinary General Meeting of April 25 2018, including the payment of a gross dividend of...

PRESS RELEASERegulated information      On 25 April 2018, Compagnie du Bois Sauvage held its Ordinary General Meeting at its headquarters. Shareholders approved all items of the agenda. Details...

Cie du Bois Sauvage - Rapport annuel 2017

COMMUNIQUE DE PRESSEInformation réglementée Les informations suivantes sont disponibles sur le site internet de la société depuis ce vendredi 23 mars 2018 : Ordre du jour de l'assemblée...

Cie du Bois Sauvage - Annual report 2017

PRESS RELEASERegulated Information The following information is available on the website of the company since this Friday, March 23, 2018: Agenda of the ordinary general meetings of April 25th...

Cie du Bois Sauvage - Résultats FY 2017

COMMUNIQUE DE PRESSE                     Information réglementée    RESULTATS Résultat opérationnel avant cessions, variations de juste valeur et dépréciations à EUR 51,1 millions (vs. EUR 39,2...

Cie du Bois Sauvage - Results FY 2017

PRESS RELEASE  Regulated Information   RESULTS  Operating results before disposals, changes in fair value and depreciations at EUR 51.1 million (vs. 39.2 million in 2016).Net result, group share...

Compagnie du Bois Sauvage : Souscription à l'augmentation de capital de Vinventions, LLC

Communiqué de presse (sous embargo jusqu'au 1er mars 2018 à 17h45) La société Vinventions, LLC (USA) a décidé d'augmenter son capital d'un montant d'USD 40 millions pour...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.080.40363269424819.8220.209919.743286219.97671094SP
4-0.17-0.84703537618320.0720.619.742658820.16591554SP
12-0.79-3.8182696955120.6920.719.722175520.18974885SP
26-0.65-3.1630170316320.5520.9818.9422364419.95598894SP
520.562.895553257519.3421.5918.92548919.9527852SP
156-5.63-22.052487269925.5335.6618.866313525.93389361SP
260-4.46-18.308702791524.3635.6617.145960925.32869625SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FCUVFocus Universal Inc
$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
$ 0.4621
(-28.80%)
7.08M
SMSTDefiance Daily Target 2x Short MSTR ETF
$ 5.69
(-26.30%)
24.62M
RAINRain Enhancement Technologies Holdco Inc
$ 5.59
(-23.42%)
155.16k
PTLEPTL Ltd
$ 9.35
(-23.30%)
967.95k
NXUNXU Inc
$ 0.725868
(-22.78%)
7.4M
NITON2OFF Inc
$ 2.6306
(145.85%)
350.92M
TGLTreasure Global Inc
$ 0.382
(101.58%)
330.82M
ACONAclarion Inc
$ 0.2984
(110.14%)
305.59M
FCUVFocus Universal Inc
$ 0.9499
(174.93%)
259.78M
NVDANVIDIA Corporation
$ 144.47
(4.45%)
222.72M

Discussion

View Full Feed
ElectricMountain53 ElectricMountain53 3 minutes ago
What Lebby said has got no value anymore. He also said deals were around the corner and many other things that haven´t come to fruition. Now he´s fired.
Let´s just wait what Yves has to say next week!!
You posting so much seems like pumping before the 9th!
Are you afraid of wh
LWLG
igotthemojo igotthemojo 26 minutes ago
i am speaking as the foremost authority on kblb that there is...bar none...i am saying that this stock is ready to fly...and will start flying BEFORE Feb...i have spoken...
KBLB
nowwhat2 nowwhat2 29 minutes ago
The Total 3

https://investorshub.advfn.com/uimage/uploads/2025/1/5/twljxtotal_3_!_5_5d_1212am_whump.jpg



Sho nuff.......Whump......Much of this is XRP but I'll betcya Doge, etc. SOL, too

https://investorshub.advfn.com/uimage/uploads/2025/1/
XRPUSD
boi568 boi568 36 minutes ago
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 48 minutes ago
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 50 minutes ago
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 52 minutes ago
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 53 minutes ago
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 53 minutes ago
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 54 minutes ago
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 56 minutes ago
The Russes hit the jackpot?
BDEZ BDEZ 57 minutes ago
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 58 minutes ago
Not good, thanks for sharing.
sand sand 1 hour ago
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 1 hour ago
Moving hard soon 
EFSH
mining101 mining101 1 hour ago
Superb
MEGL
benz280c benz280c 1 hour ago
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 1 hour ago
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 1 hour ago
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 1 hour ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 1 hour ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 2 hours ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD